NO740349L - Analogifremgangsmåte ved fremstilling av antibakterielt virksomme piperazinderivater. - Google Patents

Analogifremgangsmåte ved fremstilling av antibakterielt virksomme piperazinderivater.

Info

Publication number
NO740349L
NO740349L NO740349A NO740349A NO740349L NO 740349 L NO740349 L NO 740349L NO 740349 A NO740349 A NO 740349A NO 740349 A NO740349 A NO 740349A NO 740349 L NO740349 L NO 740349L
Authority
NO
Norway
Prior art keywords
preparation
piperazine derivatives
analogous process
antibacterial active
active piperazine
Prior art date
Application number
NO740349A
Other languages
English (en)
Other versions
NO142221B (no
NO142221C (no
Inventor
Jun-Ichi Matsumoto
Kazuyo Kawaguchi
Masanao Shimizu
Shinasku Mishio
Shinsaku Minami
Shinichi Nakamura
Yoshiyuki Takase
Original Assignee
Dainippon Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP3845373A external-priority patent/JPS5546400B2/ja
Priority claimed from JP5654473A external-priority patent/JPS565753B2/ja
Priority claimed from JP6446473A external-priority patent/JPS565755B2/ja
Application filed by Dainippon Pharmaceutical Co Ltd filed Critical Dainippon Pharmaceutical Co Ltd
Publication of NO740349L publication Critical patent/NO740349L/no
Publication of NO142221B publication Critical patent/NO142221B/no
Publication of NO142221C publication Critical patent/NO142221C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/48Two nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO740349A 1973-04-03 1974-02-04 Analogifremgangsmaate ved fremstilling av antibakterielt virksomme piperazinderivater NO142221C (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP3845373A JPS5546400B2 (no) 1973-04-03 1973-04-03
JP5654473A JPS565753B2 (no) 1973-05-21 1973-05-21
JP6446473A JPS565755B2 (no) 1973-06-07 1973-06-07

Publications (3)

Publication Number Publication Date
NO740349L true NO740349L (no) 1974-10-04
NO142221B NO142221B (no) 1980-04-08
NO142221C NO142221C (no) 1980-07-16

Family

ID=27289838

Family Applications (1)

Application Number Title Priority Date Filing Date
NO740349A NO142221C (no) 1973-04-03 1974-02-04 Analogifremgangsmaate ved fremstilling av antibakterielt virksomme piperazinderivater

Country Status (11)

Country Link
AR (2) AR204003A1 (no)
AT (1) AT340931B (no)
CA (1) CA1066701A (no)
CH (1) CH593281A5 (no)
ES (1) ES424851A1 (no)
FI (1) FI56011C (no)
IE (1) IE39102B1 (no)
NL (1) NL186087C (no)
NO (1) NO142221C (no)
PH (2) PH10529A (no)
SE (1) SE416051B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1209163B (it) * 1979-12-21 1989-07-10 Unibios S P A Trecate Novara Procedimento per la fabbricazione di: 6-alcossicarbonil-8-etil-5-oxo-5,8diidro-aperta par. quadrata 2,3-dchiusa par. quadrata-primidine 2-sostituite ed acidi libri corrispondenti.
PL2448938T3 (pl) 2009-06-29 2014-11-28 Incyte Holdings Corp Pirymidynony jako inhibitory PI3K
AR079529A1 (es) 2009-12-18 2012-02-01 Incyte Corp Derivados arilo y heteroarilo sustituidos y fundidos como inhibidores de la pi3k
WO2011075643A1 (en) 2009-12-18 2011-06-23 Incyte Corporation Substituted heteroaryl fused derivatives as pi3k inhibitors
TW201249844A (en) 2010-12-20 2012-12-16 Incyte Corp N-(1-(substituted-phenyl)ethyl)-9H-purin-6-amines as PI3K inhibitors
KR102131612B1 (ko) 2011-09-02 2020-07-08 인사이트 홀딩스 코포레이션 Pi3k 억제제로서 헤테로시클릴아민
AR090548A1 (es) 2012-04-02 2014-11-19 Incyte Corp Azaheterociclobencilaminas biciclicas como inhibidores de pi3k
WO2015191677A1 (en) 2014-06-11 2015-12-17 Incyte Corporation Bicyclic heteroarylaminoalkyl phenyl derivatives as pi3k inhibitors
MA41607B1 (fr) 2015-02-27 2021-01-29 Incyte Corp Sels d'un inhibiteur de pi3k et procédés de préparation de ces sels
WO2016183060A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Process for the synthesis of a phosphoinositide 3-kinase inhibitor
WO2016183063A1 (en) 2015-05-11 2016-11-17 Incyte Corporation Crystalline forms of a pi3k inhibitor

Also Published As

Publication number Publication date
SE416051B (sv) 1980-11-24
NO142221B (no) 1980-04-08
AR204003A1 (es) 1975-11-12
IE39102B1 (en) 1978-08-02
NO142221C (no) 1980-07-16
FI56011B (fi) 1979-07-31
IE39102L (en) 1974-10-03
ES424851A1 (es) 1976-06-01
ATA277774A (de) 1977-05-15
PH10984A (en) 1977-10-18
CH593281A5 (en) 1977-11-30
FI56011C (fi) 1979-11-12
CA1066701A (en) 1979-11-20
NL186087C (nl) 1990-09-17
PH10529A (en) 1977-05-30
NL186087B (nl) 1990-04-17
NL7401509A (no) 1974-10-07
AR204660A1 (es) 1976-02-20
AT340931B (de) 1978-01-10

Similar Documents

Publication Publication Date Title
NO741815L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive etylenderivater.
NO741227L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive penicillinderivater.
NO740670L (no) Analogifremgangsmåte for fremstilling av nye 1-aryloksy-2-hydroksy-3-alkynylaminopropanforbindelser.
NO740349L (no) Analogifremgangsmåte ved fremstilling av antibakterielt virksomme piperazinderivater.
NO143531C (no) Fremgangsmaate for fremstilling av acylerte benzoksazolinon-derivater.
NO741125A (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive pyrido-pyrimidin-derivater.
NO741223L (no) Fremgangsmåte for fremstilling av 6-deoksytetracykliner.
NO141649C (no) Analogifremgangsmaate for fremstilling av neuroleptisk aktive 7-fluorsubstituerte fenotiaziner
NO740405L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive tienotriazolodiazepinderivater.
NO740327L (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive imidazopyridiner.
NO741607L (no) Fremgangsmåte for fremstilling av isocyanater.
NO741486L (no) Fremgangsmåte for fremstilling av xylitol.
NO153806C (no) Fremgangsmaate for fremstilling av 6-deoksytetracyklin.
NO741744L (no) Analogifremgangsmåte for fremstilling av nye terapeutisk aktive derivater av naftyridin.
NO741350L (no) Analogifremgangsmåte for fremstilling av farmakologisk aktive benzylaminer.
NO740614L (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 2-fenylaminoimidazolin (2)-forbindelser.
NO147754C (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme cefemderivater.
NO741351L (no) Analogifremgangsmåte for fremstilling av fysiologisk aktive triazolo-1,5-benzodiazepiner.
SE410458B (sv) Forfarande for framstellning av vissa angivna 1,2,4-triazolderivat
NO741133L (no) Fremgangsmåte for fremstilling av metyl-3-(2-kinoksalinylmetylen)-karbazat-N1.N4-dioksyd.
SE401835B (sv) Forfarande for framstellning av 17beta-hydroxi-16,16-dimetylest-4-en-3-on
DK135685B (da) Analogifremgangsmåde til fremstilling af morfolinderivater.
NO741141L (no) Analogifremgangsmåte ved fremstilling av nye terapeutisk aktive benzopyranopyridinderivater.
NO741309L (no) Analogifremgangsmåte ved fremstilling av terapeutisk aktive seco-prostaglandiner.
NO741044L (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive triaziner.